Table of Content




1. Introduction


2. Research Methodology

3. Executive Summary


4. Global Cervical Cancer Test (Screening) Population

4.1 Asia
4.2 Europe
4.3 North America
4.4 Rest of World


5. Global Cervical Cancer Test (Screening) Market

5.1 Pap Smear Test (Screening)
5.2 HPV DNA Test (Screening)


6. By Region – Global Cervical Cancer Test (Screening) Market Analysis

6.1 Asia
6.2 Europe
6.3 North America
6.4 Rest of World


7. Population Share – Global Cervical Cancer Test (Screening)

7.1 By Region
7.2 By Countries


8. Market Share – Global Cervical Cancer Test (Screening)

8.1 Region – Cervical Cancer Test (Screening)
8.2 Countries – Cervical Cancer Test (Screening)
8.3 Countries – Pap Smear Test (Screening)
8.4 Countries – HPV DNA Test (Screening)
8.5 Countries – VIA Test (Screening)


9. United Kingdom – Cervical Cancer Test Analysis

9.1 United Kingdom Cervical Cancer Test (Screening) Population & Forecast

9.1.1 United Kingdom Pap Smear Test Population
9.1.2 United Kingdom HPV DNA Test Population

9.2 United Kingdom Cervical Cancer Deaths
9.3 United kingdom Cervical Cancer Test (Screening) Market & Forecast

9.3.1 United Kingdom Pap Smear Test Market
9.3.2 United Kingdom HPV DNA Test Market


10. France – Cervical Cancer Test Analysis

10.1 France Cervical Cancer Test (Screening) Population & Forecast

10.1.1 France Pap Smear Test Population
10.1.2 France HPV DNA Test Population

10.2 France Cervical Cancer Mortality
10.3 France Cervical Cancer Test (Screening) Market & Forecast

10.3.1 France Pap Smear Test Market
10.3.2 France HPV DNA Test Market


11. Germany – Cervical Cancer Test Analysis

11.1 Germany Cervical Cancer Test (Screening) Population & Forecast

11.1.1 Germany Pap Smear Test Population
11.1.2 Germany HPV DNA Test Population

11.2 Germany Cervical Cancer Mortality
11.3 Market – Cervical Cancer Test (Screening)

11.3.1 Germany Pap Smear Test Market
11.3.2 Germany HPV DNA Test Market


12. Italy – Cervical Cancer Test Analysis

12.1 Cervical Cancer Test (Screening) Population & Forecast

12.1.1 Italy Pap Smear Test Population
12.1.2 Italy HPV DNA Test Population

12.2 Italy Cervical Cancer Mortality
12.3 Italy Cervical Cancer Test (Screening) Market & Forecast

12.3.1 Italy Pap Smear Test Market
12.3.2 Italy HPV DNA Test Market


13. Spain – Cervical Cancer Test Analysis

13.1 Spain Cervical Cancer Test (Screening) Population & Forecast

13.1.1 Spain Pap Smear Test Population
13.1.2 Spain HPV DNA Test Population

13.2 Spain Cervical Cancer Mortality
13.3 Spain Cervical Cancer Test (Screening) Market & Forecast

13.3.1 Spain Pap Smear Test Market
13.3.2 Spain HPV DNA Test Market


14. Sweden – Cervical Cancer Test Analysis

14.1 Sweden Cervical Cancer Test (Screening) Population & Forecast

14.1.1 Sweden Pap Smear Test Population
14.1.2 Sweden HPV DNA Test Population

14.2 Sweden Cervical Cancer Mortality
14.3 Cervical Cancer Test (Screening) Market & Forecast

14.3.1 Sweden Pap Smear Test Market
14.3.2 Sweden HPV DNA Test Market


15. Switzerland – Cervical Cancer Test Analysis

15.1 Switzerland Cervical Cancer Test (Screening) Population & Forecast

15.1.1 Switzerland Pap Smear Test Population
15.1.2 Switzerland HPV DNA Test Population

15.2 Switzerland Cervical Cancer Mortality
15.3 Switzerland Cervical Cancer Test (Screening) Market & Forecast

15.3.1 Switzerland Pap Smear Test Market
15.3.2 Switzerland HPV DNA Test Market


16. Norway – Cervical Cancer Test Analysis

16.1 Norway Cervical Cancer Test (Screening) Population & Forecast

16.1.1 Norway Pap Smear Test Population
16.1.2 Norway HPV DNA Test Population

16.2 Norway Cervical Cancer Mortality
16.3 Norway Cervical Cancer Test (Screening) Market & Forecast

16.3.1 Norway Pap Smear Test Market & Forecast
16.3.2 Norway HPV DNA Test Market


17. Netherlands – Cervical Cancer Test Analysis

17.1 Netherlands Cervical Cancer Test (Screening) Population & Forecast

17.1.1 Netherlands Pap Smear Test Population
17.1.2 Netherlands HPV DNA Test Population

17.2 Netherlands Cervical Cancer Mortality
17.3 Netherlands Cervical Cancer Test (Screening) Market & Forecast

17.3.1 Netherlands Pap Smear Test Market
17.3.2 Netherlands HPV DNA Test Market


18. United States – Cervical Cancer Test Analysis

18.1 United States Cervical Cancer Test (Screening) Population & Forecast

18.1.1 United States Pap smear Test Population
18.1.2 United States HPV DNA Test Population

18.2 United States Cervical Cancer Mortality
18.3 United States Cervical Cancer Test (Screening) Market

18.3.1 United States Pap Smear Test Market
18.3.2 United States HPV DNA Test Market


19. Canada – Cervical Cancer Test Analysis

19.1 Canada Cervical Cancer Test (Screening) Population & Forecast

19.1.1 Canada Pap smear Test Population
19.1.2 Canada HPV DNA Test Population

19.2 Canada Cervical Cancer Mortality
19.3 Canada Cervical Cancer Test (Screening) Market & Forecast

19.3.1 Canada Pap Smear Test Market
19.3.2 Canada HPV DNA Test Market


20. Japan – Cervical Cancer Test Analysis

20.1 Japan Cervical Cancer Test (Screening) Population & Forecast

20.1.1 Japan Pap smear Test Population
20.1.2 Japan HPV DNA Test Population

20.2 Japan Cervical Cancer Mortality
20.3 Japan Cervical Cancer Test (Screening) Market & Forecast

20.3.1 Japan Pap Smear Test Market
20.3.2 Japan HPV DNA Test Market

21. South Korea – Cervical Cancer Tests Analysis

21.1 South Korea - Cervical Cancer Test (Screening) Population & Forecast

21.1.1 South Korea Pap Smear Test Population
21.1.2 Korea HPV DNA Test Population

21.2 Korea Cervical Cancer Mortality
21.3 Korea Cervical Cancer Test (Screening) Market & Forecast

21.3.1 Korea Pap Smear Test Market
21.3.2 Korea HPV DNA Test Market

22. Singapore – Cervical Cancer Tests Analysis

22.1 Singapore - Cervical Cancer Test (Screening) Population & Forecast

22.1.1 Singapore Pap Smear Test Population
22.1.2 Singapore HPV DNA Test Population

22.2 Singapore Cervical Cancer Test (Screening) Market & Forecast

22.2.1 Singapore Pap Smear Test Market
22.2.2 Singapore HPV DNA Test Market

23. Malaysia – Cervical Cancer Test Analysis

23.1 Malaysia - Cervical Cancer Test (Screening) Population & Forecast

23.1.1 Malaysia Pap Smear Test Population
23.1.2 Malaysia HPV DNA Test Population

23.2 Malaysia Cervical Cancer Test (Screening) Market & Forecast

23.2.1 Malaysia Pap Smear Test Market
23.2.2 Malaysia HPV DNA Test Market

24. India – Cervical Cancer Test Analysis

24.1 India - Cervical Cancer Test (Screening) Population & Forecast

24.1.1 India Pap Smear Test Population
24.1.2 India HPV DNA Test Population
24.1.3 India VIA Test Population

24.2 India Cervical Cancer Test (Screening) Market & Forecast

24.2.1 India Pap Smear Test Market
24.2.2 India HPV DNA Test Market
24.2.3 India VIA Test Market

25. China – Cervical Cancer Test Analysis

25.1 China - Cervical Cancer Test (Screening) Population & Forecast

25.1.1 China Pap Smear Test Population
25.1.2 China HPV DNA Test Population
25.1.3 China VIA Test Population

25.2 China - Cervical Cancer Test (Screening) Market & Forecast

25.2.1 China Pap Smear Test Market
25.2.2 China HPV DNA Test Market
25.2.3 China VIA Test Market

26. Thailand – Cervical Cancer Test Analysis

26.1 Thailand - Cervical Cancer Test (Screening) Population & Forecast

26.1.1 Thailand Pap Smear Test Population
26.1.2 Thailand VIA Test Population

26.2 Thailand Cervical Cancer Test (Screening) Market & Forecast

26.2.1 Thailand Pap Smear Test Market
26.2.2 Thailand VIA Test Market

27. Indonesia – Cervical Cancer Test Analysis

27.1 Indonesia Cervical Cancer Test (Screening) Population & Forecast

27.1.1 Indonesia Pap Smear Test Population
27.1.2 Indonesia HPV DNA Test Population
27.1.3 Indonesia VIA Test Population
27.1.4 Indonesia Pap Smear & VIA Test Population

27.2 Indonesia Cervical Cancer Test (Screening) Market & Forecast

27.2.1 Indonesia Pap Smear Test Market
27.2.2 Indonesia HPV DNA Test Market
27.2.3 Indonesia VIA Test Market
27.2.4 Indonesia Pap smear & VIA Test Market

28. Rest of World – Cervical Cancer Test Analysis

28.1 Rest of World Cervical Cancer Test (Screening) Population & Forecast

28.1.1 Rest of World Pap smear Test Population
28.1.2 Rest of World HPV DNA Test Population

28.2 Rest of World Cervical Cancer Test (Screening) Market & Forecast

28.2.1 Rest of World Pap Smear Test Market
28.2.2 Rest of World HPV DNA Test Market

29. Growth Drivers

29.1 Introduction of Low Cost VIA Test

29.1.1 Countries Offering VIA Test via National Programs
29.1.2 Countries Offering VIA Test via Pilot Programs

29.2 Worldwide High Prevalence of HPV Infected Patients
29.3 Rising Number of Incidence of Cervical Cancer in United Kingdom
29.4 Worldwide Rising Incidence of Teenage Sexual Cases


30. Challenges


30.1 Lack of Appropriate Healthcare Infrastructure

30.2 Introduction of HPV Vaccination Programs Worldwide



List of Figures



Figure 2_1: Global – Cervical Cancer Test Population (Million), 2013 – 2019
Figure 2_2: Global – Forecast for Cervical Cancer Test Population (Million), 2020 – 2026
Figure 2_3: Asia – Cervical Cancer Test Population (Million), 2013– 2019
Figure 2_4: Asia – Forecast for Cervical Cancer Test Population (Million), 2020 – 2026
Figure 2_5: Europe – Cervical Cancer Test Population (Million), 2013 – 2019
Figure 2_6: Europe – Forecast for Cervical Cancer Test Population (Million), 2020 – 2026
Figure 2_7: North America – Cervical Cancer Test Population (Million), 2013 – 2019
Figure 2_8: North America – Forecast for Cervical Cancer Test Population (Million), 2020 – 2026
Figure 3_1: Global – Cervical Cancer Test Market (Million US$), 2014 – 2019
Figure 3_2: Global – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 3_3: Global – Cervical Cancer Pap Smear Test Market (Million US$), 2013 – 2019
Figure 3_4: Global – Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2020 – 2026
Figure 3_5: Global – Cervical Cancer HPV DNA Test Market (Million US$), 2013 – 2019
Figure 3_6: Global – Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2020 – 2026
Figure 4_1: Asia – Cervical Cancer Test Market (Million US$), 2014 – 2019
Figure 4_2: Asia – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 4_3: Europe – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 4_4: Europe – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 4_5: North America – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 4_6: North America – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 5_1: Global - Cervical Cancer Test (Screening) Population Share (Percent) by Region Figure 5_2: Global – Forecast for Cervical Cancer Test (Screening) Population Share (Percent) by Region, 2020 – 2026
Figure 6_1: Global – Cervical Cancer Market Share (Percent) By Region, 2014 – 2019
Figure 6_2: Global – Forecast for Cervical Cancer Market Share (Percent) By Region, 2020 – 2026
Figure 7_1: United Kingdom – Cervical Cancer Test Population (Thousand), 2014 – 2019
Figure 7_2: United Kingdom – Forecast for Cervical Cancer Test Population (Thousand), 2020 – 2026
Figure 7_3: United Kingdom – Cervical Cancer Pap Smear Test Population (Thousand), 2014 – 2019
Figure 7_4: United Kingdom – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 – 2026
Figure 7_5: United Kingdom – Cervical Cancer HPV DNA Test Population (Thousand), 2014 – 2019
Figure 7_6: United Kingdom – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 – 2026
Figure 7_7: United Kingdom – Cervical Cancer Deaths (Number), 2014 – 2019
Figure 7_8: United Kingdom – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 7_9: United Kingdom – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 7_10: United Kingdom – Pap Smear Test Market (Million US$), 2013 – 2019
Figure 7_11: United Kingdom – Forecast for Pap Smear Test Market (Million US$), 2020 – 2026
Figure 7_12: United Kingdom – HPV DNA Test Market (Million US$), 2013 – 2019
Figure 7_13: United Kingdom – Forecast for HPV DNA Test Market (Million US$), 2020 – 2026
Figure 8_1: France – Cervical Cancer Test Population (Thousand), 2013 – 2019
Figure 8_2: France – Forecast for Cervical Cancer Test Population (Thousand), 2020 – 2026
Figure 8_3: France – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 8_4: France – Forecast for Cervical Cancer Pap Smear Test Population (Thousand) Figure 8_5: France – Cervical Cancer HPV DNA Test Population (Thousand), 2013 – 2019
Figure 8_6: France – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 – 2026
Figure 8_7: France – Cervical Cancer Mortality (Number), 2013 – 2020
Figure 8_8: France – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 8_9: France – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 8_10: France – Pap Smear Test Market (Million US$), 2013 – 2019
Figure 8_11: France – Forecast for Pap Smear Test Market (Million US$), 2020 – 2026
Figure 8_12: France – HPV DNA Test Market (Million US$), 2013 – 2019
Figure 8_13: France – Forecast for HPV DNA Test Market (Million US$), 2020 – 2026
Figure 9_1: Germany – Cervical Cancer Test Population (Thousand), 2013 – 2019
Figure 9_2: Germany – Forecast for Cervical Cancer Test Population (Thousand), 2020 – 2026
Figure 9_3: Germany – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 9_4: Germany – Forecast for Cervical Cancer Pap Smear Test Population (Thousand) Figure 9_5: Germany – Cervical Cancer HPV DNA Test Population (Thousand), 2013 – 2019
Figure 9_6: Germany – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 – 2026
Figure 9_7: Germany – Cervical Cancer Mortality (Number), 2011 – 2017
Figure 9_8: Germany – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 9_9: Germany – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 9_10: Germany – Pap Smear Test Market (Million US$), 2013 – 2019
Figure 9_11: Germany – Forecast for Pap Smear Test Market (Million US$), 2020 – 2026
Figure 9_12: Germany – HPV DNA Test Market (Million US$), 2013 – 2019
Figure 9_13: Germany – Forecast for HPV DNA Test Market (Million US$), 2020 – 2026
Figure 10_1: Italy – Cervical Cancer Test Population (Thousand), 2013 – 2019
Figure 10_2: Italy – Cervical Cancer Test Population (Thousand), 2020 – 2026
Figure 10_3: Italy – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 10_4: Italy – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 – 2026
Figure 10_5: Italy – Cervical Cancer HPV DNA Test Population (Thousand), 2013 – 2019
Figure 10_6: Italy – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 – 2026
Figure 10_7: Italy – Cervical Cancer Mortality (Number), 2013 – 2020
Figure 10_8: Italy – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 10_9: Italy – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 10_10: Italy – Pap Smear Test Market (Million US$), 2013 – 2019
Figure 10_11: Italy – Forecast for Pap Smear Test Market (Million US$), 2020 – 2026
Figure 10_12: Italy – HPV DNA Test Market (Million US$), 2013 – 2019
Figure 10_13: Italy – Forecast for HPV DNA Test Market (Million US$), 2020 – 2026
Figure 11_1: Spain – Cervical Cancer Test Population (Thousand), 2013 – 2019
Figure 11_2: Spain – Forecast for Cervical Cancer Test Population (Thousand), 2020 – 2026
Figure 11_3: Spain – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 11_4: Spain – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 – 2026
Figure 11_5: Spain – Cervical Cancer HPV DNA Test Population (Thousand), 2013 – 2019
Figure 11_6: Spain – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 –2026
Figure 11_7: Spain – Cervical Cancer Mortality (Number), 2013 – 2020
Figure 11_8: Spain – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 11_9: Spain – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 11_10: Spain – Pap Smear Test Market (Million US$), 2013 – 2019
Figure 11_11: Spain – Forecast for Pap Smear Test Market (Million US$), 2020 – 2026
Figure 11_12: Spain – HPV DNA Test Market (Million US$), 2013 – 2019
Figure 11_13: Spain – Forecast for HPV DNA Test Market (Million US$), 2020 – 2026
Figure 12_1: Sweden – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 12_2: Sweden – Forecast for Cervical Cancer Pap smear Test Population (Thousand) Figure 12_3: Sweden – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 12_4: Sweden – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 – 2026
Figure 12_5: Sweden – Cervical Cancer HPV DNA Test Population (Thousand), 2013 – 2019
Figure 12_6: Sweden – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 – 2026
Figure 12_7: Sweden – Cervical Cancer Mortality (Number), 2013 – 2019
Figure 12_8: Sweden – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 12_9: Sweden – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 12_10: Sweden – Pap Smear Test Market (Million US$), 2013 – 2019
Figure 12_11: Sweden – Forecast for Pap Smear Test Market (Million US$), 2020 – 2026
Figure 12_12: Sweden – HPV DNA Test Market (Million US$), 2013 – 2019
Figure 12_13: Sweden – Forecast for HPV DNA Test Market (Million US$), 2020 – 2026
Figure 13_1: Switzerland – Cervical Cancer Test Population (Thousand), 2013 – 2019
Figure 13_2: Switzerland – Forecast for Cervical Cancer Test Population (Thousand), 2020-2026
Figure 13_3: Switzerland – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 13_4: Switzerland – Forecast for Cervical Cancer Pap Smear Test Population (Thousand) Figure 13_5: Switzerland – Cervical Cancer HPV DNA Test Population (Thousand), 2013 – 2019
Figure 13_6: Switzerland – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 – 2026
Figure 13_7: Switzerland – Cervical Cancer Mortality (Number), 2013 – 2020
Figure 13_8: Switzerland – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 13_9: Switzerland – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 13_10: Switzerland – Pap Smear Test Market (Million US$), 2013 – 2019
Figure 13_11: Switzerland – Forecast for Pap Smear Test Market (Million US$), 2020 – 2026
Figure 13_12: Switzerland – HPV DNA Test Market (Million US$), 2013 – 2019
Figure 13_13: Switzerland – Forecast for HPV DNA Test Market (Million US$), 2020 – 2026
Figure 14_1: Norway – Cervical Cancer Test Population (Thousand), 2013 – 2019
Figure 14_2: Norway – Forecast for Cervical Cancer Test Population (Thousand), 2020 – 2026
Figure 14_3: Norway – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 14_4: Norway – Forecast for Cervical Cancer Pap Smear Test Population (Thousand) Figure 14_5: Norway – Cervical Cancer HPV DNA Test Population (Thousand), 2013 – 2019
Figure 14_6: Norway – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 – 2026
Figure 14_7: Norway – Cervical Cancer Mortality (Number), 2013 – 2019
Figure 14_8: Norway – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 14_9: Norway – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 14_10: Norway – Pap Smear Test Market (Million US$), 2013 – 2019
Figure 14_11: Norway – Forecast for Pap Smear Test Market (Million US$), 2020 – 2026
Figure 14_12: Norway – HPV DNA Test Market (Million US$), 2013 – 2019
Figure 14_13: Norway – Forecast for HPV DNA Test Market (Million US$), 2020 – 2026
Figure 15_1: Netherlands – Cervical Cancer Test Population (Thousand), 2013 – 2019
Figure 15_2: Netherlands – Forecast for Cervical Cancer Test Population (Thousand), 2020 – 2026
Figure 15_3: Netherlands – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 15_4: Netherlands – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020– 2026
Figure 15_5: Netherlands – Cervical Cancer HPV DNA Test Population (Thousand), 2013 – 2019
Figure 15_6: Netherlands – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 – 2026
Figure 15_7: Netherlands – Cervical Cancer Mortality (Number), 2013 – 2020
Figure 15_8: Netherlands – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 15_9: Netherlands – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 15_10: Netherlands – Pap Smear Test Market (Million US$), 2013 – 2019
Figure 15_11: Netherlands – Forecast for Pap Smear Test Market (Million US$), 2020 – 2026
Figure 15_12: Netherlands – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 15_13: Netherlands – Forecast for HPV DNA Test Market (Million US$), 2020 – 2026
Figure 16_1: United States – Cervical Cancer Test Population (Thousand), 2013 – 2019
Figure 16_2: United States – Forecast for Cervical Cancer Test Population (Thousand), 2020 – 2026
Figure 16_3: United States – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 16_4: United States – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 – 2026
Figure 16_5: United States – Cervical Cancer HPV DNA Test Population (Thousand), 2013 – 2019
Figure 16_6: United States – Forecast for Cervical Cancer HPV DNA Test Population (Thousand) Figure 16_7: United States – Cervical Cancer Mortality (Number), 2013 – 2019
Figure 16_8: United States – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 16_9: United States – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 16_10: United States – Pap smear Test Market (Million US$), 2013 – 2019
Figure 16_11: United States – Forecast for Pap Smear Test Market (Million US$), 2020 – 2026
Figure 16_12: United States – HPV DNA Test Market (Million US$), 2013 – 2019
Figure 16_13: United States – Forecast for HPV DNA Test Market (Million US$), 2020 – 2026
Figure 17_1: Canada – Cervical Cancer Test Population (Thousand), 2013 – 2019
Figure 17_2: Canada – Forecast for Cervical Cancer Test Population (Thousand), 2020 – 2026
Figure 17_3: Canada – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 17_4: Canada – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 – 2026
Figure 17_5: Canada – Cervical Cancer HPV DNA Test Population (Thousand), 2013 – 2019
Figure 17_6: Canada – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 – 2026
Figure 17_7: Canada – Cervical Cancer Mortality (Number), 2013 – 2019
Figure 17_8: Canada – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 17_9: Canada – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 17_10: Canada – Pap Smear Test Market (Million US$), 2013 – 2019
Figure 17_11: Canada – Forecast for Pap Smear Test Market (Million US$), 2020 – 2026
Figure 17_12: Canada – HPV DNA Test Market (Million US$), 2013 – 2019
Figure 17_13: Canada – Forecast for HPV DNA Test Market (Million US$), 2018 – 2024
Figure 18_1: Japan – Cervical Cancer Test Population (Thousand), 2013 – 2019
Figure 18_2: Japan – Forecast for Cervical Cancer Test Population (Thousand), 2020– 2026
Figure 18_3: Japan – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 18_4: Japan – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 – 2026
Figure 18_5: Japan – Cervical Cancer HPV DNA Test Population (Thousand), 2013 – 2019
Figure 18_6: Japan – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 – 2026
Figure 18_7: apan – Cervical Cancer Mortality (Number), 2013 – 2020
Figure 18_8: Japan – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 18_9: Japan – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 18_10: Japan – Pap Smear Test Market (Million US$), 2013 – 2019
Figure 18_11: Japan – Forecast for Pap Smear Test Market (Million US$), 2020 – 2026
Figure 18_12: Japan – HPV DNA Test Market (Million US$), 2013 – 2019
Figure 18_13: Japan – Forecast for HPV DNA Test Market (Million US$), 2020 – 2026
Figure 19_1: Korea – Cervical Cancer Test Population (Thousand), 2013 – 2019
Figure 19_2: Korea – Forecast for Cervical Cancer Test Population (Thousand), 2020 – 2026
Figure 19_3: Korea – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 19_4: Korea – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 – 2026
Figure 19_5: Korea – Cervical Cancer HPV DNA Test Population (Thousand), 2013 – 2019
Figure 19_6: Korea – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 – 2026
Figure 19_7: Korea – Cervical Cancer Mortality (Number), 2013 – 2020
Figure 19_8: Korea – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 19_9: orea – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 19_10: Korea – Pap Smear Test Market (Million US$), 2013 – 2019
Figure 19_11: Korea – Forecast for Pap Smear Test Market (Million US$), 2020 – 2026
Figure 19_12: Korea – HPV DNA Test Market (Million US$), 2013 – 2019
Figure 19_13: Korea – Forecast for HPV DNA Test Market (Million US$), 2020 – 2026
Figure 20_1: Singapore – Cervical Cancer Test Population (Thousand), 2013 – 2019
Figure 20_2: Singapore – Forecast for Cervical Cancer Test Population (Thousand), 2020 – 2026
Figure 20_3: Singapore – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 20_4: Singapore – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 – 2026
Figure 20_5: Singapore – Cervical Cancer HPV DNA Test Population (Thousand), 2013 – 2019
Figure 20_6: Singapore – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2018 – 2024
Figure 20_7: Singapore – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 20_8: Singapore – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 20_9: Singapore – Pap Smear Test Market (Million US$), 2013 – 2019
Figure 20_10: Singapore – Forecast for Pap Smear Test Market (Million US$), 2020 – 2026
Figure 20_11: Singapore – HPV DNA Test Market (Million US$), 2013 – 2019
Figure 20_12: Singapore – Forecast for HPV DNA Test Market (Million US$), 2020 – 2026
Figure 21_1: Malaysia – Cervical Cancer Test Population (Thousand), 2013 – 2019
Figure 21_2: Malaysia – Forecast for Cervical Cancer Test Population (Thousand), 2020 – 2026
Figure 21_3: Malaysia – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 21_4: Malaysia – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 – 2026
Figure 21_5: Malaysia – Cervical Cancer HPV DNA Test Population (Thousand), 2013 – 2019
Figure 21_6: Malaysia – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 – 2026
Figure 21_7: Malaysia – Cervical Cancer Test Market (Million US$), 2013– 2019
Figure 21_8: Malaysia – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 21_9: Malaysia – Pap smear Test Market (Million US$), 2013 – 2019
Figure 21_10: Malaysia – Forecast for Pap smear Test Market (Million US$), 2020 – 2026
Figure 21_11: Malaysia – HPV DNA Test Market (Million US$), 2011 – 2017
Figure 21_12: Malaysia – Forecast for HPV DNA Test Market (Million US$), 2020– 2026
Figure 22_1: India – Cervical Cancer Test Population (Thousand), 2013 – 2019
Figure 22_2: India – Forecast for Cervical Cancer Test Population (Thousand), 2020 – 2026
Figure 22_3: India – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 22_4: India – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 – 2026
Figure 22_5: India – Cervical Cancer HPV DNA Test Population (Thousand), 2013 – 2019
Figure 22_6: India – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 – 2026
Figure 22_7: India – Cervical Cancer VIA Test Population (Thousand), 2013 – 2019
Figure 22_8: India – Forecast for Cervical Cancer VIA Test Population (Thousand), 2020 – 2026
Figure 22_9: India – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 22_10: India – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 22_11: India – Pap smear Test Market (Million US$), 2013 – 2019
Figure 22_12: India – Forecast for Pap smear Test Market (Million US$), 2020 – 2026
Figure 22_13: India – HPV DNA Test Market (Million US$), 2013 – 2019
Figure 22_14: India – Forecast for HPV DNA Test Market (Million US$), 2020 – 2026
Figure 22_15: India – VIA Test Market (Million US$), 2013 – 2019
Figure 22_16: India – Forecast for VIA Test Market (Million US$), 2020 – 2026
Figure 23_1: China – Cervical Cancer Test Population (Thousand), 2013 – 2019
Figure 23_2: China – Forecast for Cervical Cancer Test Population (Thousand), 2020 – 2026
Figure 23_3: China – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 23_4: China – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 – 2026
Figure 23_5: China – Cervical Cancer HPV DNA Test Population (Thousand), 2013 – 2019
Figure 23_6: China – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 – 2026
Figure 23_7: China – Cervical Cancer VIA Test Population (Thousand), 2013 – 2019
Figure 23_8: China – Forecast for Cervical Cancer VIA Test Population (Thousand), 2020 – 2026
Figure 23_9: China – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 23_10: China – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 23_11: China – Pap smear Test Market (Million US$), 2013 – 2019
Figure 23_12: China – Forecast for Pap Smear Test Market (Million US$), 2020 – 2026
Figure 23_13: China – HPV DNA Test Market (Million US$), 2013 – 2019
Figure 23_14: China – Forecast for HPV DNA Test Market (Million US$), 2020 – 2026
Figure 23_15: China – VIA Test Market (Million US$), 2013 – 2019
Figure 23_16: China – Forecast for VIA Test Market (Million US$), 2020 – 2026
Figure 24_1: Thailand – Cervical Cancer Test Population (Thousand), 2013 – 2019
Figure 24_2: Thailand – Cervical Cancer Test Population (Thousand), 2020 – 2026
Figure 24_3: Thailand – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 24_4: Thailand – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 – 2026
Figure 24_5: Thailand – Cervical Cancer VIA Test Population (Thousand), 2013 – 2019
Figure 24_6: Thailand – Forecast for Cervical Cancer VIA Test Population (Thousand), 2020 – 2026
Figure 24_7: Thailand – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 24_8: Thailand – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 24_9: Thailand – Pap smear Test Market (Million US$), 2013 – 2019
Figure 24_10: Thailand – Forecast for Pap Smear Test Market (Million US$), 2020 – 2029
Figure 24_11: Thailand – VIA Test Market (Million US$), 2013 – 2019
Figure 24_12: Thailand – Forecast for VIA Test Market (Million US$), 2020 – 2026
Figure 25_1: Indonesia – Cervical Cancer Test Population (Thousand), 2013 – 2019
Figure 25_2: Indonesia – Forecast for Cervical Cancer Test Population (Thousand), 2020 – 2026
Figure 25_3: Indonesia – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 25_4: Indonesia – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 – 2026
Figure 25_5: Indonesia – Cervical Cancer HPV DNA Test Population (Thousand), 2013 – 2019
Figure 25_6: Indonesia – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020 – 2026
Figure 25_7: Indonesia – Cervical Cancer VIA Test Population (Thousand), 2013 – 2019
Figure 25_8: Indonesia – Forecast for Cervical Cancer VIA Test Population (Thousand), 2020 – 2026
Figure 25_9: Indonesia – Cervical Cancer Both (Pap smear & VIA) Test Population (Thousand), 2013 – 2019
Figure 25_10: Indonesia – Forecast for Cervical Cancer Both (Pap smear & VIA) Test Population (Thousand), 2020 – 2026
Figure 25_11: Indonesia – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 25_12: Indonesia – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 25_13: Indonesia – Pap Smear Test Market (Million US$), 2013 – 2019
Figure 25_14: Indonesia – Forecast for Pap Smear Test Market (Million US$), 2020 – 2026
Figure 25_15: Indonesia – HPV DNA Test Market (Million US$), 2013 – 2019
Figure 25_16: Indonesia – Forecast for HPV DNA Test Market (Million US$), 2020 – 2026
Figure 25_17: Indonesia – VIA Test Market (Million US$), 2013 – 2019
Figure 25_18: Indonesia – Forecast for VIA Test Market (Million US$), 2020 – 2026
Figure 25_19: Indonesia – Both (Pap smear & VIA) Test Market (Million US$), 2013 – 2019
Figure 25_20: Indonesia – Forecast for Both (Pap smear & VIA) Test Market (Million US$), 2020 – 2026
Figure 26_1: Rest of World – Cervical Cancer Test Population (Thousand), 2013 – 2019
Figure 26_2: Rest of World – Forecast for Cervical Cancer Test Population (Thousand), 2020 – 2026
Figure 26_3: Rest of World – Cervical Cancer Pap Smear Test Population (Thousand), 2013 – 2019
Figure 26_4: Rest of World – Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2020 – 2026
Figure 26_5: Rest of World – Cervical Cancer HPV DNA Test Population (Thousand), 2013 – 2019
Figure 26_6: Rest of World – Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2020– 2026
Figure 26_7: Rest of World – Cervical Cancer Test Market (Million US$), 2013 – 2019
Figure 26_8: Rest of World – Forecast for Cervical Cancer Test Market (Million US$), 2020 – 2026
Figure 26_9: Rest of World – Pap Smear Test Market (Million US$), 2013 – 2019
Figure 26_10: Rest of World – Forecast for Pap Smear Test Market (Million US$), 2020 – 2026
Figure 26_11: Rest of World – HPV DNA Test Market (Million US$), 2013 – 2019
Figure 26_12: Rest of World – Forecast for HPV DNA Test Market (Million US$), 2020 – 2026


List of Tables



Table 5_1: Global –Cervical Cancer Test Population Share (Percent) By Country, 2014 – 2019
Table 5_2: Global – Forecast for Cervical Cancer Test Population Share (Percent) by Country Table 6_1: Global – Cervical Cancer Test Market Share (Percent) by Country, 2014 – 2019
Table 6_2: Global – Forecast for Cervical Cancer Test Market Share (Percent) by Country, 2020 – 2026
Table 6_3: Global – Pap Smear Test Market Share (Percent), 2014 – 2019
Table 6_4: Global – Forecast for Pap Smear Test Market Share (Percent), 2020 – 2026
Table 6_5: Global – HPV DNA Test Market Share (Percent), 2014 – 2019
Table 6_6: Global – Forecast for HPV DNA Test Market Share (Percent), 2020 – 2026
Table 6_7: Global – VIA Test Market Share (Percent), 2013 – 2019
Table 6_8: Global – Forecast for VIA Test Market Share (Percent), 2020 – 2026
Table 26_1: Worldwide – List of Countries which offer VIA Test via National Programs, 2015
Table 26_2: Worldwide – List of Countries which offer VIA Test via Pilot Programs, 2015
Table 26_3: Worldwide – Prevalence of HPV 16/18 in Women with Normal Cervical Cytology (Percent), 2014 - 2015
Table 26_4: United Kingdom – Number of Incidence Observed and Projected and their respective Age Standardized Rate, 2010 - 2025
Table 26_5: Worldwide – Prevalence (Percent) of Young Women (15–44 Years) who Have Sex before the Age of 15 Years, 1994 – 2006